Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal analgesia to prevent postoperative delirium after spinal fusion in elderly patients
ChiCTR2400085956Phase 4Not yet recruiting
- Sponsor
- Ganzhou People's Hospital
- Start
- Jun 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine, sufentanil and ketorolac in postoperative pain and postoperative delirium (POD) (3 arms), sponsored by Ganzhou People's Hospital. Primary endpoints: interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and 1 more. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
dexmedetomidinesufentanilketorolac
03
Conditions
postoperative painpostoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2400085956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085956.